Yuanyuan Gao Selected Research

Hypoxia (Hypoxemia)

1/2022

BMS-470539 Attenuates Oxidative Stress and Neuronal Apoptosis via MC1R/cAMP/PKA/Nurr1 Signaling Pathway in a Neonatal Hypoxic-Ischemic Rat Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanyuan Gao Research Topics

Disease

15	Neoplasms (Cancer) 11/2023 - 11/2008
10	Inflammation (Inflammations) 05/2023 - 01/2014
6	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 01/2019
5	Wounds and Injuries (Trauma) 01/2023 - 03/2020
4	Fibrosis (Cirrhosis) 02/2024 - 07/2016
4	Starvation 06/2023 - 01/2019
4	Bacterial Infections (Bacterial Infection) 01/2023 - 09/2020
3	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 05/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2020
3	Shock 01/2022 - 01/2019
3	Diabetes Mellitus 01/2022 - 01/2014
3	Carcinogenesis 01/2021 - 11/2008
3	Infections 09/2020 - 01/2016
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 07/2015
2	Encephalitis (Encephalitis, Rasmussen) 12/2023 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 11/2023 - 01/2021
2	Breast Neoplasms (Breast Cancer) 03/2023 - 01/2019
2	Hypertension (High Blood Pressure) 01/2023 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2021
2	Skin Diseases (Skin Disease) 11/2022 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2015
2	Stroke (Strokes) 01/2021 - 01/2017
2	Hyperplasia 01/2021 - 07/2015
2	Liver Diseases (Liver Disease) 01/2021 - 01/2015
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2021 - 01/2021
2	Movement Disorders (Movement Disorder) 01/2021 - 01/2021
1	Cross Infection (Nosocomial Infection) 01/2024
1	Fever (Fevers) 12/2023
1	Dystonia (Limb Dystonia) 12/2023
1	Nervous System Diseases (Neurological Disorders) 12/2023
1	Rabies (Hydrophobia) 11/2023
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Reperfusion Injury 05/2023
1	Necrosis 05/2023
1	Triple Negative Breast Neoplasms 03/2023
1	Glucose Intolerance 01/2023
1	Esophagitis 01/2023
1	Paralysis (Palsy) 01/2023
1	Vaginitis 01/2023

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2014
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2019
4	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2015
4	NitrogenIBA 06/2023 - 07/2016
4	Peptides (Polypeptides)IBA 01/2022 - 01/2018
3	AntibodiesIBA 12/2023 - 08/2020
3	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 09/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2019
3	PolyphenolsIBA 11/2022 - 03/2015
3	AminoglycosidesIBA 01/2022 - 01/2019
3	AndrogensIBA 01/2022 - 01/2019
3	CytokinesIBA 05/2021 - 01/2017
3	AntioxidantsIBA 04/2021 - 01/2018
3	CollagenIBA 01/2018 - 07/2016
2	Rituximab (Mabthera)FDA Link 12/2023 - 01/2023
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 11/2023 - 01/2023
2	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2023 - 03/2023
2	CarbonIBA 06/2023 - 09/2022
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2021
2	Polysaccharides (Glycans)IBA 01/2023 - 05/2021
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2022 - 11/2014
2	ChitosanIBA 11/2022 - 03/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 01/2019
2	Hormones (Hormone)IBA 01/2022 - 01/2015
2	InterferonsIBA 05/2021 - 01/2020
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2021 - 01/2021
2	CreatinineIBA 01/2021 - 01/2019
2	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2020 - 01/2019
2	Imiquimod (Aldara)FDA LinkGeneric 01/2019 - 01/2017
2	FlavonoidsIBA 01/2019 - 03/2015
2	Transcription Factors (Transcription Factor)IBA 10/2017 - 08/2017
2	AgarIBA 12/2009 - 11/2008
1	human MIRN503 microRNAIBA 11/2023
1	human MIRN1247 microRNAIBA 11/2023
1	DNA VaccinesIBA 11/2023
1	EpitopesIBA 11/2023
1	OrexinsIBA 11/2023
1	Gemcitabine FDA Link 10/2023
1	Phosphorus (Red Phosphorus)IBA 06/2023
1	AnisomycinIBA 05/2023
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 05/2023
1	p38 Mitogen-Activated Protein KinasesIBA 05/2023
1	baicaleinIBA 03/2023
1	methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA 03/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2023
1	fibroblast growth factor 13IBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2023
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 01/2023
1	Reducing AgentsIBA 01/2023
1	CholesterolIBA 01/2023

Therapy/Procedure

11	Therapeutics 03/2023 - 01/2015
3	Immunotherapy 05/2024 - 01/2021
3	Drug Therapy (Chemotherapy) 03/2023 - 01/2015
1	Precision Medicine 02/2024
1	Intravenous Injections 03/2023
1	Aftercare (After-Treatment) 01/2023